|
US5308850A
(en)
|
1991-09-30 |
1994-05-03 |
Merck Frosst Canada, Inc. |
(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
US5290798A
(en)
|
1991-09-30 |
1994-03-01 |
Merck Frosst Canada, Inc. |
(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
JPH06145150A
(ja)
|
1992-11-09 |
1994-05-24 |
Kyowa Hakko Kogyo Co Ltd |
イミダゾール誘導体
|
|
AU4967797A
(en)
|
1996-11-19 |
1998-06-10 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzofuran derivatives
|
|
DE69728688T2
(de)
|
1996-11-19 |
2004-08-19 |
Amgen Inc., Thousand Oaks |
Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel
|
|
WO1998057931A2
(en)
|
1997-06-19 |
1998-12-23 |
Sepracor Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
DE69842143D1
(de)
|
1997-10-24 |
2011-04-07 |
Nissan Chemical Ind Ltd |
Sulfamoyl-verbindungen und bakterizide für landwirtschaft oder gartenbau
|
|
GB9902453D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
CA2386750A1
(en)
|
1999-10-22 |
2001-05-03 |
Merck & Co. Inc. |
Pharmaceuticals for treating obesity
|
|
AU2001280187A1
(en)
|
2000-08-28 |
2002-03-13 |
Toray Industries, Inc. |
Cyclic amine derivatives
|
|
AU2001296193B2
(en)
|
2000-10-20 |
2006-04-27 |
Biovitrum Ab |
2-, 3-, 4-, or 5-substituted-N1-(benzensulfonyl)indoles and their use in therapy
|
|
EP2298738B1
(en)
|
2000-11-02 |
2012-09-19 |
Wyeth LLC |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
US6503907B2
(en)
*
|
2000-11-28 |
2003-01-07 |
Hoffmann-La Roche Inc. |
Indole and dihydroindole derivatives
|
|
MXPA03005432A
(es)
|
2000-12-22 |
2003-09-10 |
Wyeth Corp |
Compuestos de heterociclilindazol y -azaindazol como ligandos de 5-hidroxitriptamina-6.
|
|
EP1487776A4
(en)
|
2002-03-27 |
2005-05-25 |
Smithkline Beecham Corp |
ACID COMPOUNDS AND ESTERS AND METHODS OF USE THEREOF
|
|
WO2004000831A1
(en)
|
2002-06-24 |
2003-12-31 |
Schering Corporation |
Indole derivatives useful as histamine h3 antagonists
|
|
ES2228267B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
|
GB0323845D0
(en)
|
2003-10-10 |
2003-11-12 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
AU2005211807C1
(en)
|
2004-02-11 |
2009-07-16 |
Irm Llc |
Compounds and compositions as LXR modulators
|
|
WO2005085188A2
(en)
|
2004-03-02 |
2005-09-15 |
Compass Pharmaceuticals Llc |
Compounds and methods for anti-tumor therapy
|
|
JP4682192B2
(ja)
*
|
2004-05-03 |
2011-05-11 |
エフ．ホフマン−ラ ロシュ アーゲー |
肝ｘ受容体モジュレータとしてのインドリル誘導体
|
|
WO2005113499A1
(ja)
*
|
2004-05-20 |
2005-12-01 |
Sankyo Company, Limited |
インドール化合物
|
|
JP2008509138A
(ja)
*
|
2004-08-03 |
2008-03-27 |
ワイス |
心臓血管疾患の治療に有用なインダゾール類
|
|
WO2006050236A2
(en)
|
2004-11-01 |
2006-05-11 |
Nuada, Llc |
Compounds and methods of use thereof
|
|
WO2007134169A2
(en)
|
2006-05-10 |
2007-11-22 |
Nuada, Llc |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
WO2006109633A1
(ja)
*
|
2005-04-07 |
2006-10-19 |
Daiichi Sankyo Company, Limited |
置換インドール化合物
|
|
FR2886293B1
(fr)
*
|
2005-05-30 |
2007-08-24 |
Fournier S A Sa Lab |
Nouveaux composes de l'indoline
|
|
TW200745031A
(en)
*
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
|
US20070142369A1
(en)
|
2005-12-21 |
2007-06-21 |
Margaret Van Heek |
Combination of an H3 antagonist/inverse agonist and an appetite suppressant
|
|
WO2008003736A1
(en)
|
2006-07-06 |
2008-01-10 |
Solvay Pharmaceuticals B.V. |
Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition
|
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
|
US8507469B2
(en)
|
2007-03-23 |
2013-08-13 |
Abbott Gmbh & Co. Kg |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
CA2681809C
(en)
*
|
2007-03-30 |
2012-06-05 |
F. Hoffmann-La Roche Ag |
Imidazolidinone derivatives
|
|
GB0708141D0
(en)
*
|
2007-04-26 |
2007-06-06 |
Syngenta Participations Ag |
Improvements in or relating to organic compounds
|
|
ATE541845T1
(de)
|
2007-08-29 |
2012-02-15 |
Schering Corp |
2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
|
|
WO2009032116A1
(en)
|
2007-08-29 |
2009-03-12 |
Schering Corporation |
2, 3-substituted indole derivatives for treating viral infections
|
|
MX2010005356A
(es)
|
2007-11-16 |
2010-05-27 |
Schering Corp |
Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos.
|
|
CA2705587A1
(en)
|
2007-11-16 |
2009-05-22 |
Schering Corporation |
3-aminosulfonyl substituted indole derivatives and methods of use thereof
|
|
WO2010010186A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
EP2210891A1
(en)
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
New adenosine receptor ligands and uses thereof
|
|
EP2245936A1
(en)
|
2009-04-27 |
2010-11-03 |
Bayer CropScience AG |
Use of 4-aza indole derivatives for the reduction of mycotoxin contamination
|
|
BRPI1010587A2
(pt)
|
2009-06-08 |
2019-04-09 |
Acceleron Pharma Inc. |
métodos para aumentar adipócitos termogênicos
|
|
US8609653B2
(en)
|
2011-07-15 |
2013-12-17 |
Glaxosmithkline Llc |
Azaindole compounds and methods for treating HIV
|
|
WO2013028999A1
(en)
|
2011-08-24 |
2013-02-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders
|
|
BR112014015298B1
(pt)
|
2011-12-22 |
2021-06-15 |
Connexios Life Sciences Pvt. Ltd |
Composto derivado de aza-adamantano, composição farmacêutica e uso do composto
|
|
KR20130142801A
(ko)
|
2012-06-20 |
2013-12-30 |
안국약품 주식회사 |
１１β－ＨＳＤ１ 효소의 억제활성을 갖는 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
US9376420B2
(en)
|
2012-10-25 |
2016-06-28 |
Yuhan Corporation |
4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
|
|
WO2014085453A2
(en)
|
2012-11-29 |
2014-06-05 |
The Scripps Research Institute |
Small molecule lxr inverse agonists
|
|
JP6442475B2
(ja)
*
|
2013-03-15 |
2018-12-19 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｌｘｒ調節因子
|
|
EP2990403A1
(en)
|
2014-08-29 |
2016-03-02 |
Novartis Tiergesundheit AG |
Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
|
|
JP2018500388A
(ja)
|
2014-11-18 |
2018-01-11 |
ラットガーズ、ザ ステート ユニバーシティ オブ ニュージャージー |
代謝疾患及び癌の治療のための、新規ミトコンドリアアンカップラー
|
|
TW201630907A
(zh)
|
2014-12-22 |
2016-09-01 |
必治妥美雅史谷比公司 |
ＴＧＦβＲ拮抗劑
|
|
FR3037959B1
(fr)
*
|
2015-06-23 |
2017-08-04 |
Servier Lab |
Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US10227315B2
(en)
|
2016-05-18 |
2019-03-12 |
Rutgers, The State University Of New Jersey |
Mitochondrial uncouplers for treatment of metabolic diseases and cancer
|
|
UY37659A
(es)
*
|
2017-04-10 |
2018-10-31 |
Phenex Fxr Gmbh |
Moduladores del receptor x del hígado (lxr)
|
|
TWI683808B
(zh)
*
|
2017-07-18 |
2020-02-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有胺或(硫)醯胺之lxr調節劑
|
|
SI3796975T1
(sl)
|
2018-05-22 |
2024-02-29 |
Orsobio, Inc. |
Derivati sulfonilaminobenzamida
|
|
TWI748194B
(zh)
|
2018-06-28 |
2021-12-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有雙環核心部分之新穎lxr調節劑
|
|
WO2020257283A1
(en)
|
2019-06-18 |
2020-12-24 |
Mitopower Llc |
Nicotinyl riboside compounds and their uses
|
|
EP4611746A1
(en)
|
2022-11-03 |
2025-09-10 |
OrsoBio, Inc. |
Lxr modulators with bicyclic core moiety for treating dyslipidemias
|